Business Description
Medicale Corp
NAICS : 424430
SIC : 5145
ISIN : US58464K1025
Total Employee Number:
1Compare
Compare
Traded in other countries / regions
MCLE.USA IPO Date
2021-11-19Description
Medicale Corp is plans to offer consulting services and distribution of dietary supplements. A dietary supplement is a manufactured product intended to supplement the diet when taken by mouth as a pill, capsule, tablet, or liquid. A supplement can provide nutrients either extracted from food sources or synthetic, individually or in combination, in order to increase the quantity of their consumption.
Financial Strength
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Debt-to-Equity | -0.78 | |||||
Debt-to-EBITDA | -5.14 | |||||
Piotroski F-Score | N/A/9 | |||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 5 | |||||
3-Year EPS without NRI Growth Rate | -12.6 | |||||
3-Year Book Growth Rate | -38.7 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 30.57 | |||||
9-Day RSI | 35.42 | |||||
14-Day RSI | 38.52 | |||||
3-1 Month Momentum % | 16.56 | |||||
6-1 Month Momentum % | 173.46 | |||||
12-1 Month Momentum % | -56.14 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History |
|---|
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Shareholder Yield % | -18.92 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROIC % | -183.33 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | N/A |
N/A
|
N/A
| |||
PE Ratio without NRI | N/A |
N/A
|
N/A
| |||
EV-to-EBIT | -11.86 | |||||
EV-to-EBITDA | -11.86 | |||||
EV-to-FCF | -13.05 | |||||
Earnings Yield (Greenblatt) % | -8.43 | |||||
FCF Yield % | -13.51 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:MCLE
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Medicale Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | - | ||
| Beta | -8.2451 | ||
| 3-Year Sharpe Ratio | 0.7 | ||
| 3-Year Sortino Ratio | 2.56 | ||
| Volatility % | 539.83 | ||
| 14-Day RSI | 38.52 | ||
| 14-Day ATR ($) | 0.008041 | ||
| 20-Day SMA ($) | 0.046555 | ||
| 12-1 Month Momentum % | -56.14 | ||
| 52-Week Range ($) | 0.022 - 6.35 | ||
| Shares Outstanding (Mil) | 5.92 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Medicale Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Medicale Corp Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Medicale Corp Frequently Asked Questions
What is Medicale Corp(MCLE)'s stock price today?
The current price of MCLE is $0.03. The 52 week high of MCLE is $6.35 and 52 week low is $0.02.
When is next earnings date of Medicale Corp(MCLE)?
The next earnings date of Medicale Corp(MCLE) is .
Does Medicale Corp(MCLE) pay dividends? If so, how much?
Medicale Corp(MCLE) does not pay dividend.
Guru Commentaries on OTCPK:MCLE
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Medicale Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers